ACETAMINOPHEN AMIKACIN ASCORBIC ACID

(PARACETAMOL)
Amikacide 50,125,250mg/ml c-4-kids 100mg/ml drops
TD: 15–22.5 mkday ÷ Q8 IV/IM
Aeknil Amicyn 100,250mg/ml 100mg/5ml syr
TD: 100–300 mg/24 hr ÷ OD-BID
300mg/2 ml amp Amikin 100,250,500mg/ml ceelin 100mg/ml drops
Tempra/Biogesic/Calpol 100mg/5ml syr
100mg/ml drops AMINOPHYLLINE 100mg/chew tab
TD: 10-15 mkdose Q4-6 Neonatal apnea:
120mg/5ml
Neonates: 10-15 mkdose Q6-8 LD: 5–6 mg/kg IV
250mg/5ml Amilin 25 mg/mL amp ASPIRIN
MD: 1–2 mkdose Q6–8 IV Analgesic/antipyretic:
Opigesic
10–15 mkdose PO/PR Q4–6
125mg & 250 mg supp Aspilets 80mg/tab
Asthma exacerbation Max. dose: 4 g/24 hr
Rexidol 80mg/EC tab
IV LD: 6 mg/kg IV over 20 min
600 mg/tab Bayprin 100mg/EC tab
(each 1.2 mg/kg dose raises the Anti-inflammatory:
150mg/5ml Cor-30 30mg/tab
serum theophylline 60–100 mkday PO ÷ Q6–8
concentration 2 mg/L)
ACETYLCYSTEINE
IV MD: Continuous IV drip or total Kawasaki disease:
daily doses IV ÷ Q4–6 hr 80–100 mkday PO ÷ QID then
Fluimucil 600mg/tab Granules: 100mg BID-QID
3–5 mkday hr PO QAM. Continue
100mg & 200mg Inh: 1 amp OD-BID for ≥5-10 days
Neonate: 0.2 mkhr for 8 wk or until Plt Ct and ESR are
(sachet) Inj (IM): ½ amp OD-BID
6 wk–6 mo: 0.5 mkhr normal
100mg/5ml Inj (IV): 1-1½ amp BID-TID. It is
6 mo–1 yr: 0.6–0.7 mkhr
100mg/ml (inh) recommended to dilute IV inj w/ AZITHROMYCIN
1–9 yr: 1–1.2 mkhr AOM, CAP, & sinusitis* (≥6 mo)
100mg/ml (inj) 0.9% NaCl soln or a 5% glucose
9–12 yr and smoker: 0.9 mkhr PO-OD:
soln. Zenith 200mg/5ml/susp
>12 yr nonsmoker: 0.7 mkhr 5 days: 10 mg/kg D1, then 5 mg/kg
Zithromax 200mg/5ml/susp
3 days: 10 mkday*
AMOXICILLIN 250 & 500mg/tab
1 day: 30 mkday
ACYCLOVIR Neonate: 20–30 mkday ÷ Q12 PO 500mg/vial
Varicella (≥2 yr):
Pediamox 100mg/ml drops
IV: 30 mkday ÷ Q8 × 7–10 d ATP (2–15 yr): 12 mkday x 5 days
Herpex 200,400,800mg tab 250mg/5ml Child: 25–50 mkday ÷ Q8–12 PO
PO: 80 mkday ÷ QID × 5 d
200mg/5ml Himox 100mg/ml drops BAMBUTEROL
Zovirax 200,400,800mg tab 125mg/5ml High dose: 80–90 mkday ÷ BID PO 2-5 yr: 10 mg (10 mL) OD
Zoster:
250mg/vial 250mg/5ml Bambec 1mg/ml/sol’n 6-12 yr: Initially 10 mg, may be
IV: 30 mkday ÷ Q8 × 7–10 d
Hapivir 400 mg/5 mL 10mg/tab increased to 20 mg after 1-2 wk.
PO (12 yr): 4000 mday ÷ Q5 × 5-7
AMOXICILLIN–CLAVULANIC
ALBUTEROL (SALBUTAMOL) ACID BISACODYL
PO: 0.3 mg/kg/dose or 5–10 mg, 6
Nebulization:
1–<3 mo: 30 mkday ÷ Q12 PO hr prior to effect
Ventolin 2.5mg/2.5mL neb <1 yr: 0.05–0.15 mkdose Q4–6 Amoclav 228.5mg/5ml susp Dulcolax 5mg/ped supp
2mg/5mL syr 1–5 yr: 1.25–2.5 mdose Q4–6 457mg/5ml susp 10mg/adult sup
≥3 mo: suppository (as a single dose):
2mg tab 5–12 yr: 2.5 mdose Q4–6 Pediaclav 312.5mg/5ml susp 5mg/tab
TID: 20–40 mkday ÷ Q8 PO <2 yr: 5 mg
Asmalin 1mg/mL pulmoneb >12 yr: 2.5–5 mdose Q4–8 Augmentin 156.25/5ml susp
2–11 yr: 5–10 mg
2mg/5ml Syr 228.5mg/5ml susp
BID: 25–45 mkday ÷ Q12 PO >11 y: 10 mg
Oral: 312.5mg/5ml susp
2–6 yr: 0.3 mkday ÷ TID 457mg/5ml susp
enema (>12 yr): 30 mL
6–12 yr: 6 mday÷ TID
>12 yr 2–4 mdose TID–QID AMPICILLIN CALCIUM CARBONATE
Hypocalcemia:
PO: 50–100 mkday ÷ Q6 hr 112.5-162.5 mkday ÷ QID
ALUMINUM HYDROXIDE + Ampicin 250,500 mg vial Tums 500mg chew tabs
MAGNESIUM HYDROXIDE 500 mg cap
IM/IV: 100–200 mkday ÷ Q6 Antacid (PO):
Excillin 250,500 mg, 1g vial
2–5 yr: 400 mg
Maalox
TD: 300–900 mg PO 1–3 hr PC and Severe infections: 200–400 mkday >6–11 yr: 800 mg
Chewtab: Al(OH)3 200 mg,
HS ÷ Q4–6 IM/IV >11 yr: 1000–3000 mg
Mg(OH)2 200 mg
Per 5mL susp Al(OH)3 225 mg, CALCIUM GLUCONATE Hypocalcemia (Infant):
Mg(OH)2 200 mg AMPICILLIN-SULBACTAM IV: 200–500 mkday ÷ Q6
<30 kg: 25-50 mkday ÷ Q12 PO
Calcinate 100 mg/mL PO: 400–800 mkday ÷ Q6
>30 kg: 375-750 mg BID
AMBROXOL Unasyn 250 mg/5ml susp Child: 200–500 mkday IV/0PO ÷ Q6
TD: 1.2-1.6 mkdose TID 375,750 mg, 1.5g
IM/IV
Ambrolex 7.5mg/ml drops <2 yr 5-10 drops Ampimax 750mg, 1g vial Cardiac arrest:
≥ 1 mo: 100–150 mkday ÷ Q6
15mg/5ml syr 2-5 yr 10-20 drops TD: 100 mg/kg/dose IV Q10 min
Menin.: 200–300 mkday ÷ Q6
30mg/5ml syr <2 yr 2.5 ml
Mucosolvan 6mg/ml drops 2-5 yr 2.5 ml Tetany: 100–200 mkdose IV over
Child:: 100–200 mkday ÷ Q6
30mg/5ml syr 6-11 yr 5 ml 5–10 min, repeat 6 hr later if
Mening.: 200–400 mkday ÷ Q4–6
15mg/5ml syr needed
CARBAMAZEPINE <6 yr LD: 10-20 mkday P.O. BID-TID CEFOTAXIME CIMETIDINE
or QID (susp), < 12 yr or < 50 kg: 100-200mkday Q6-8 Neonate: 5–20 mkday PO ÷ Q6–12
Tegretol 100mg/5ml susp Increment: Q5-7days. Cladex 1g vial Meningitis: 200mkday Q6 Cimulcer 100mg/ml amp Infant: 10–20 mkday PO ÷ Q6–12
200mg tab Max: of 35 mkday Claforan 500mg vial >12 yr or ≥50 kg: 1–2 g/dose Q6–8 Tagamet 200 & 400mg tab Child: 20–40 mkday PO ÷ Q6
200mg SR tab IV/IM
400mg LA tab 6-12 yr LD: 10 mkday P.O. BID CIPROFLOXACIN
increment: 100 mday (TID-QID) Q CEFOTETAN TD: 40–80 mkday ÷ Q12 IV/IM PO: 20–30 mkday ÷ Q12; max 1.5 g/d
1 wk CEFOXITIN Ciprobay 250 & 500mg tab IV: 20–30 mkday ÷ Q12; max 800 mg/d
MD: 20-30 mkday BID-QID Mild/moderate infections: 80–100
500mg & 1g XR tab
Max: 1000 mday mkday ÷ Q6–8 IM/IV
Monowel/Panafox 100mg/50ml vial Comp. UTI or pyeloneph (×10–21 d):
1g vial 200mg/100ml vial PO: 20–40 mkday ÷ Q12; max 1.5 g/d
>12 yr Initial: 200 mg PO BID Severe infections: 100–160 mkday ÷
400mg/200ml vial IV: 18–30 mkday ÷ Q8; max 1.2 g/d
Increment: 200 mday Q 1wk Q4–6 IM/IV
(÷BID–QID) until desired response CEFPODOXIME CLARITHROMYCIN
is obtained Otitis media: 10 mkday PO ÷ Q12–24 ×
MD: 800–1200 mday PO ÷ BID– 5 days
Trizef 50mg/5ml susp Klaz 125mg/5ml susp
QID 100mg tab 250mg/5ml susp
CEFACLOR Pharyngitis/tonsillitis: 10 mkday PO ÷
Cefadox 200mg tab 250 & 500mg tab TD: 15 mkday PO ÷ Q12
Ceclor 125mg/5ml susp Q12 hr × 5–10 days
Klaz OD 500mg/mod rel tab
TD: 20–40 mkday PO ÷ Q8
250mg/5ml susp CEFTAZIDIME Klaricid 250 & 500mg tab.
50mg/ml drops Klaricid OD 500mg/mod rel tab
Otitis media: 40 mkday Q12 TD: 100–150 mkday ÷ Q8 IV/IM
Pharex 125mg/5ml susp Fortum 250 & 500mg vial
250mg/5ml susp 1 & 2 g vial CLINDAMYCIN
Pharyngitis: 20 mkday Q12 CF/Meningitis: 150 mkday ÷ Q8 IV/IM
200 & 500mg cap Zeptrigen 500mg & 1g vial
Neonate: 5mkdose Q8-12 hr
Dalacin C 75 mg/5 ml sol’n
PO: 10–30 mkday ÷ Q6–8; max 1.8 g/d
CEFADROXIL CEFTRIAXONE 150/ml amp
IM/IV: 25–40 mkday ÷ Q6–8
Infant/child: 50-75 mkd Q12 150 & 300mg cap
Cefadrox 500mg/cap Forgram 500mg & 1g vial
TD: 30 mg/kg/24 hr PO ÷ Q12 hr
-500 Megion 1g vial Typhoid meningitis: 75-100mkd Q12 CLONAZEPAM
Drozid 125mg/5ml syr <10 yr or <30 kg
Initial: 0.01–0.03 mkday ÷ Q8 PO.
CEFUROXIME Rivotril 2mg tab
IM/IV: Max Di: 0.05 mkday
CEFAZOLIN Clonotril-0.5 500 mcg tab
Neonate: 50–100 mkday ÷ Q12 Increment: 0.25–0.5 mday Q3 days, up
TD: 50-100mkday Q8 IV Zinnat 125mg/5ml susp to max MD of 0.1–0.2 mkday ÷ Q8
Stancef 500mg & 1g vial >3 mo-child: 75–150 mkday ÷ Q8
250mg/5ml susp
250 & 500mg tab ≥ 10 yr or ≥ 30 kg
CEFALEXIN PO (3 mo–12 yr):
Zegen 750mg & 1.5g vial Initial: 1.5 mday PO ÷ TID
TD: 25–100 mkday PO ÷ Q6 hr. Pharyngitis and tonsillitis:
250 & 500mg tab Increment: 0.5–1 mday Q3 days; max.
Cefalin 100mg/ml drops Oral suspension: 20 mkday ÷ Q12
Zinacef 250 & 750mg vial dose 20 mday
125mg/5ml susp Otitis media: 75–100 mkday PO ÷ Tabs: 125 mg PO Q12
1.5g vial
250mg/5ml susp Q6 250 & 500mg tab CLOXACILLIN
Ceporex 100mg/ml drops Otitis media, impetigo, and sinusitis:
PO: 50-100 mkd Q6
125mg/5ml susp Strep Pharyngitis and skin Oral suspension: 30 mkday ÷ Q12
Pharex 125 & 250mg/5ml IV: 100 mkd Q6
250mg/5ml susp infections: 25–50 mkday PO ÷ Q6– Tabs: 250 mg Q12 hr
250 & 500mg cap 12 CETIRIZINE COTRIMOXAZOLE (SMZ-TM)
Minor/moderate infections (PO or IV)
CEFEPIME Alllerkid 2.5mg/ml drops Bactrim 200mg/40mg/5ml Child: 8–12 mkday ÷ BID
TD: 100mkd Q12 IV 5mg/5ml syrup 6mo-< 2yr: 2.5mg OD Septrin 200mg/40mg/5ml
Axera 500mg, 1g & 2 g Alnix 10mg/tab 2-5 yr: 2.5-5mg OD Trim-S 200mg/40mg/5ml Severe infections (PO or IV)
vial Meningitis: 150mkd Q8 IV Virlix 10mg/ml drops ≥6 yr: 5-10mg OD Trim-S Forte 400mg/80mg/5ml Child: 20 mkday ÷ Q6–8
Cepimax 500mg, 1g & 2 g 1mg/ml sol’n Trizole 400mg/80mg/5ml
vial Cystic Fibrosis: 150mkd Q8 IV 10mg tab
DESLORATIDINE
CEFIXIME CHLORAMPHENICOL 6-11 mo: 1mg or 2ml
Neonate
Aerius 2.5mg/5ml/syr 1-5 yr: 1.25mg 2.5ml
Tergecef 20mg/ml drops TD: 8mkday Q12-24⁰ LD: 20mg/kg
Pediachlor 125 mg/5 mL susp 5mg/tab 6-11 yr: 2.5mg or 5ml
100mg/5ml susp MD (12 hrs after LD): 25-50mkday
100 & 200 mg cap UTI: 16mkday Q12 (Di) then 8 mkd
Ultraxime 20mg/ml drops x 13 days Infant: 50-75mkday IV Q6
100mg/5ml susp Meningitis: 75-100 mkd Q6
CHLORPHENIRAMINE MALEATE Child < 12 yr: 0.35 mkday PO ÷ Q4–6
CEFOPERAZONE TD: 100-150mkday Q8-12 2–5 yr: 1 mdose PO Q4–6
6–11 yr: 2 mdose PO Q4–6
≥12 yr: 4 mg/dose PO Q4–6
DEXAMETHASONE DOMPERIDONE ESOMEPRAZOLE GERD (use for up to 8 weeks) PO:
Airway edema: 0.5–2 mkday IV/IM
1–11 yr: 10mg OD
÷ Q6 (24 hr before extubation &
Decilone 500mcg & 4mg tab Motilium 1mg/ml drops Susp: 2.5 mL/10 kg TID Nexium 10mg gran for sol’n ≥12 yr: 20–40mg OD
for 4–6 doses after extubation)
5mg/ml amp 10mg tab Drops: 2.5-5 mg/10 kg or 20 & 40mg tab
Oradexon 500mcg tab Vometa 5mg/ml drops 0.3-0.6 mL/5 kg 40 mg vial GERD w/ erosive esophagitis (IV):
Croup: 0.6 mkdose PO/IV/IM × 1
Drenex 750mcg & 3mg tab 5mg/5ml susp FT: 0.2-0.4 mkdose Q4-8 hr Infant: 0.5-1 mkdose OD
RiteMED 500mcg tab Vometa FT 10mg fast melt tab <55 kg: 10mg OD
Anti-inflammatory: 0.08–0.3
Dexamet 5mg/ml amp ≥55 kg: 20-40mg OD
mkday PO, IV, IM ÷ Q6–12
DOXYCYCLINE Di ≤45 kg: 2.2 mkdose BID PO/IV
MD ≤45 kg: 2.2–4.4 mkday OD– FAMOTIDINE
Brain tumor: ≥3 mo–1 yr: 0.5 mkdose PO Q12 hr
Doxin 100mg cap BID PO/IV
LD: 1-2mkdose IV/IM
Vibramycin 100mg cap H2Bloc 20mg tab
MD: 1-1.5mkday Q4-6 Child (1–12 yr):
Di >45 kg: 100 mdose BID PO/IV 20mg vial
IV Initial: 0.6–0.8 mkday ÷ Q8–12
DESONIDE MD >45 kg: 100–200 mday ÷ OD–
PO: Initial: 1–1.2 mkday ÷ Q8–12
BID PO/IV
2-3x daily Peptic ulcer: 0.5 mkday PO QHS or
Desowen cream/lotion .05%
÷ Q12
Malaria prophylaxis (start 1–2
GERD: 1–2 mkday PO ÷ Q12
DIAZEPAM Sedative/muscle relaxant: days before exposure, and
IM or IV: 0.04–0.2 mkdose Q2–4; continue for 4 wk after leaving FUROSEMIDE IM, IV:
Trankil 5mg/ml amp max. dose 0.6 mg/kg within an 8- endemic area): Neonate: 0.5–1 mkdose Q8–24;
Valium 5 & 10mg tab hr period >8 yr: 2 mkday PO once daily Lasix 20mg/2ml amp max. dose 2 mg/kg/dose
10mg/2ml amp PO: 0.12–0.8 mkday ÷ Q6–8 40mg tab Infant & child: 1–2 mkdose Q6–12
EPINEPHRINE
Asystole and bradycardia:
Status epilepticus: PO:
Neonate
Neonate: 0.3–0.75 mkdose IV Adrenin 1mg/ml Infant and child: 2 mkdose; may
0.01–0.03 mg/kg of 1:10,000
Q15–30 min × 2–3 doses; max. increase by 1–2 mkdose Q6–8
solution (0.1–0.3 mL/kg) IV/ET
dose: 2 mg. after prev dose. Max. dose: 6
Q3–5 min PRN
mkdsoe.
> 1 mo: 0.2–0.5 mg/kg/dose IV
Infant and child:
Q15–30 min; max. dose <5 yr, 5 FURAZOLIDONE
Di: 0.01 mg/kg of 1:10,000 solution
mg; ≥5 yr, 10 mg. 1-3 yr: 5-7.5ml TID-QID
(0.1 mL/kg) IO/IV; max. dose 1 mg
May repeat dosing in 2–4 hr as Diapectolin 50mg/5ml susp ≥4 yr: 7.5-15ml TID-QID
(10 mL).
needed.
Subsequent doses Q3–5 min PRN
GENTAMICIN
Rectal dose: 0.5 mkdose, followed
Bronchodilator: 1:1000 (aqueous): TD: 7.5 mg/kg/24 hr ÷ Q8 hr
by 0.25 mkdose in 10 min PRN Servigenta 80mg/2ml amp
Infant and child: 0.01 mL/kg/dose Neonates: 4mkdose Q24
DICYCLOVERINE Mycin 40mg/ml amp
SC (max. sdose 0.5 mL); repeat
6 mo-2 yr: 0.5 – 1ml
Q15 min × 3–4 doses or Q4 PRN
Relestal 5mg/ml drops 2-5 yr: 2.5 – 5ml GLYCERIN Neonate: 0.5 mLkdose PR as an
10mg/5ml syr 6-12 yr: 5ml enema OD PRN
Nebulization (alternative to
racemic epinephrine): 0.5 mL/kg < 6 yr: 2–5 mL PR as an enema or 1
DIPHENHYDRAMINE of 1:1000 solution diluted in 3 mL infant suppPR OD PRN
Severe allergic reaction and
NS. >6 yr: 5–15 mL PR as an enema or
dystonic reactions (PO/IM/IV):
Benadryl AH 12.5mg/5ml syr 1 adult supp PR OD PRN
Child: 1–2 mkdose Q6
25 & 50mg cap ERTAPENEM TD: 15 mg/kg/dose IV/IM Q12 hr HYDROCORTISONE Status asthmaticus:
usual dose: 5 mkday ÷ Q6
Hyphen 50mg/ml amp ERYTHROMYCIN Child:
Max. dose: 50 mdose & 300 mday
ETHYLSUCCINATE/ESTOLATE Solu-Cortef 100mg vial LD (optional): 4–8 mkdose IV;
Sleep aid (PO/IM/IV): 250mg vial max. dose of 250 mg
Pharex 250mg/5ml susp 500mg vial MD: 8 mkday ÷ Q6IV
2–11 yr: 1 mkdose 30 min before TD: 30–50 mg/kg/24 hr ÷ Q6–8 hr
Ilosone 100mg/ml drops
bedtime.
125mg/5ml susp Anti-inflammatory:
DIVALPROEX SODIUM Ilosone DS 250mg/5ml susp Child:
Di: 10–15 mkday ÷ OD–TID
PO: 2.5–10 mkday ÷ Q6–8
Increment: 5–10 mkday at weekly
Depakote 125mg sprinkle cap ERDOSTEINE TD: 10 mkday BID IM/IV: 1–5 mkday ÷ Q12–24
intervals to max. dose of 60 mkday
/ER XR 250& 500mg tab Ectrin: Adolescent PO/IM/IV: 15–240
MD: 30–60 mkday ÷ BID–TID.
Ectrin 175mg/5mL susp >30 kg: 10 mL BID mdose Q12
DILOXANIDE FUROATE 300mg cap 20-30 kg: 5 mL TID HYDROXYZINE
TD: 20m kday ÷ Q8 hr x 7-10 days
Zertin 175mg/5mL susp 15-19 kg: 5 mL BID
300mg cap Iterax 2mg/ml syr TD: 2 mkday PO ÷ Q6–8 PRN
Zertin: 10 & 25mg tab
>12 yr (>30 kg): 7.5 mL BID
7-12 yr (21-30 kg): 5 mL BID
2-6 yr (10-20 kg): 2.5 mL BID
HYOSCINE-N-BUTYLBROMIDE MEFENAMIC ACID PANTOPRAZOLE
TD: 0.3-0.6mg/kg/day wt SIVP
<6 yr: ¼ amp TID SC/IM/IV GERD (limited data):
Buscopan 10mg tab Ponstan 50mg/5ml susp Pantoloc 20 & 40mg tab
>6 yr: 1-2 tabs 3-5x/day or 1-2 TD: 19.5-25 mkday ÷ TID <5 yr: 1.2 mkday PO OD
20mg amp 500mg tab 40mg gran
amps SC/IM/IV ≥5 yr: 20 or 40 mg PO OD
250 & 500mg SFcap 40mg vial
IBUPROFEN
METHYLPREDNISOLONE PENICILLIN G – Na+ or K+ salt IM/IV: 100,000–400,000 ukday ÷
Advil 100mg/5ml susp Anti-inflammatory: 0.5–1.7 mkday Q4–6 (use higher dose & Q4
Brufen 100mg/5ml susp Medrol 4 & 16mg tab ÷ Q6–12 PO/IM/IV interval for meningitis & severe
TD: 5–10 mg/kg/dose Q6–8 hr PO
Dolan FP 100mg/2.5ml drops Solu-Medrol infections)
100mg/5ml susp 125mg/2ml vial Asthma exacerbation (3-10 days)
200mg/5ml susp 40mg/ml vial ≤2 yr: 1–2 mkday ÷ Q12–24 PENICILLIN G —BENZATHINE Group A strep: 600,000 udose IM
500mg/8ml vial >12 yr: 40–60 mday ÷ Q12–24 ×
IPRATROPIUM BROMIDE Rheumatic fever: 600,000 udose
Infant: 125–250 mcg/dose Q8 METOCLOPRAMIDE GERD: 0.1–0.2 mg/kg/dose up to IM Q3–4 wk
Atrovent 0.5mg/2ml ≤ 12 yr: 250 mcg/dose Q6–8 QID IV/IM/PO PENICILLIN V
Child: 25–50 mkday ÷ Q6–8 PO
Plasil 5mg/5ml syr
Adol: 125–500 mg/dose PO Q6–8
IRON (FeSO4 - 20% elemental Child: 3–6 mg elemental Fe/kg/24 10mg tab Antiemetic: 1–2 mkdose Q2–6
Fe) hr ÷ OD–TID PO 10mg/2ml amp IV/IM/PO (Premedicate with PHENOBARBITAL LD: 15–20 mkdose IV (max. loading
LACTULOSE diphenhydramine to reduce EPS.) dose: 1000 mg). May give
METRONIDAZOLE Luminal 130mg/ml amp additional 5-mg/kg doses Q15–30
Duphalac 3.3g/5ml syr TD: 1–3 mL/kg/24 hr PO ÷ BID min to a max. total of 40 mg/kg.
Movelax 3.3g/5ml syr Flagyl 125mg/5ml Amebiasis: 35–50 mkday PO ÷ TID
500mg tab × 10 days MD:: Monitor levels.
LANSOPRAZOLE 500mg/100ml inf Neonate: 3–5 mkday PO/IV ÷ OD–
BID
Prevacid 15 & 30mg cap ≤30 kg: 15 mg PO OD MIDAZOLAM Infant: 5–6 mkday PO/IV ÷ OD–BID
15 & 30mg FDT tab >30 kg: 30 mg PO OD–BID 1–5 yr: 6–8 mkday PO/IV ÷ OD–BID
Refrac. status epilepticus ≥2 mo
30mg vial Dormicum 15mg tab 6–12 yr: 4–6 mkday PO/IV ÷ OD–
LD: 0.15 mg/kg IV × 1 then
5mg/ml amp BID
Cont. inf: 1 mcg/kg/ min; titrate
LEVOFLOXACIN 5mg/5ml amp >12 yr: 1–3 mkday PO/IV ÷ OD–BID
dose upward Q5 min to effect
10mg/3ml amp
Levox 500 & 750mg tab <5 yr: 10 mkdose IV/PO Q12 Hyperbilirubinemia (<12 yr):
250mg/50ml ≥5 yr: 10 mkdose IV/PO Q24 MONTELUKAST 3–8 mkday PO ÷ BID–TID
500mg/100ml PHENYLEPHRINE HCL
Oral decongestant (see remarks):
Kastair 10mg tab 6 mo–5 yr: 4 mg PO QHS
4–<6 yr (2.5 mg/mL): 1 mL (2.5
LEVODROPOPIZINE Singulair 4mg gran 6–14 yr: 5 mg PO QHS
>2 yr: 1 mg/kg mg) PO Q4 hr; max 6ml/day
4 & 5mg chew tab ≥15 yr: 10 mg PO QHS
>12 yr: 10 mL (2.5 mg/5 mL): 5 mL (2.5 mg) PO
Levopront 30mg/5ml syr 10 mg tab
10-20 kg: 3 mL Q4 hr, max: 30ml/day
20-30 kg:5 mL ≥6–<12 yr (2.5 mg/5 mL): 10 mL (5
NIFUROXAZIDE
mg) PO Q4 hr up to 60 ml/day
LORATIDINE > 2 yr: 660mg/d ÷ TID x 7 d
Ercefuryl 218mg/5ml susp PHENYTOIN
> 6 yr: 3-4 cap/day x 7 d LD (all ages): 15–20 mg/kg IV
Allerta 5mg/5ml syr 2–5 yr: 5 mg PO once daily 200mg cap
Max. dose: 1500 mg/24 hr
Claritin 5mg/5ml syr ≥6 yr: 10 mg PO once daily Dilantin 30mg/5ml susp
10mg tab NITROFURANTOIN 125mg/5ml susp
MD: (12 hr after LD):
> 1 mo: 5–7 mkday ÷ Q6 PO 100mg cap
Neonate: 5 mkday PO/IV ÷ Q12.
MEBENDAZOLE Pinworms: 100 mg PO × 1 Macrodantin 50 & 100mg cap ≥12 yr: 50-100 mdose Q6 PO 50mg/ml
Usual range is 4–8 mkday PO/IV ÷
Hook, round, & whipworm: 100 Q8–12
Antiox 20mg/ml susp mg PO BID × 3 days or 500 mg PO OMEPRAZOLE Infant/child: 5 mkday ÷ BID–TID
50mg/ml susp × 1. PO/IV.
TD: 1 mkday PO ÷ OD–BID or
500mg tab Losec 10 & 20mg cap Usual dose ranges are (doses
5–<10 kg: 5 mg PO OD
Capillariasis: 200 mg PO BID × 20 40mg amp & vial divided BID–TID):
10–<20 kg: 10 mg PO OD
days Omepron 20 & 40mg cap 6 mo–3 yr: 8–10 mg/kg/24 hr
≥20 kg: 20 mg PO OD
40mg vial 4–6 yr: 7.5–9 mg/kg/24 hr
Visceral larva migrans: 100–200 7–9 yr: 7–8 mg/kg/24 hr
mg PO BID × 5 days OXACILLIN TD: 100–200 mkday ÷ Q4–6 10–16 yr: 6–7 mg/kg/24 hr
OXYMETAZOLINE
Trichinellosis: 200–400 mg PO TID PIPERACILLIN WITH 2–9 mo: 240 mkday ÷ Q8
2-5 yr: 2-3 drops per nostril bid TAZOBACTAM >9 mo: 300 mkday ÷ Q8
× 3 days, then 400–500 mg PO TID Drixine Ped nasal drops 0.025 %
>5 yr: 2-3 spray per nostril bid
× 10 Days Drixine nasal spray 0.05 %
PREDNISONE TETRACYCLINE Dimetapp 2-6 yr: 2.5 mL Q4-6
Antiinflammatory: 0.5–2 mkday ≥8 yr: 25–50 mkday PO ÷ Q6 (Per 5 mL syrup: Brompheniramine maleate 2 6-12 yrs: 5 mL Q4-6
PO ÷ OD–BID mg, phenyl-ephrine HCl 5 mg)
Prolix 10mg/5ml susp TICARCILLIN AND 12 yrs: 10 mL Q4-6
Mild/mod infections: 200 mkday
20mg tab CLAVULANATE
Acute asthma: 2 mkday PO ÷ OD– IV ÷ Q6
Unicort 10mg/5ml susp
BID × 5–7 days Severe infections: 300 mkday IV ÷
Q4–6 Ambrolex drops 7.5 mg/mL
PROCATEROL 2-5 yr:10-20 drops TID
(ambroxol)
TRANEXAMIC ACID <2 yr: 5-10 drops TID
Meptin 5mcg/ml syr ≤5 yr: 0.25ml/kg BID-TID
25 & 50mcg tab >6 yr: 5ml or 25mcg tab OD-BID Ambrolex Ped syr 15 mg/5 mL 6-11 yr: 5 mL TID
Hemostan 250mg/2.5ml amp
TD: 15-25 mkday ÷ BID-QID (ambroxol) 2-5 yr: 2.5 mL TID
10mcg/puff inhaler 500mg/5ml amp
250 & 500mg cap <2 yr: 2.5 mL TID
PROMETHAZINE Nausea & vomiting PO/IM/IV/PR Asmalin Broncho Syrup >12 yr: 10-20 mL Q8-12
(Per 5 mL syr Guaifenesin 50 mg, salbutamol 1 7-12 yr: 10 mL Q8-12
≥2 yr: 0.25–1 mkdose Q4–6 PRN; VALPROIC ACID Di: 10–15 mkday PO ÷ OD–TID mg)
Promet 25mg/ml amp max. dose: 25 mg/dose Inc: 5–10 mkday per wk to max. 2-6 yr: 5-10 mL Q8-12
Depakene 250mg/5ml syr dose of 60 mkday Loviscol Infant drops 50 mg/mL
Motion sickness: MD: 30–60 mg/kg/24 hr ÷ BID–TID (carbocisteine) 13-24 mo:1.2 mL Q6
≥2 yr: 0.5 mkdose Q12 PO/PR PRN; VANCOMYCIN
max. dose: 25 mg/dose TD: 15-20 mg/kg Q6 Loviscol Ped syr 100 mg/5 mL 8-12 yr: 10-15ml Q8
(carbocisteine) 4-7 yr: 7.5-10ml Q8
PYRANTEL PAMOATE Vancocin 500mg vial
1-3 yr: 5-7.5ml Q8
Combantrin 125mg, 250mg tab Mucosolvan drops 6mg/mL 13-24 mo: 1.25 mL BID
(ambroxol) 7-12 mo: 1 mL BID
125mg/5ml TD: 11mkdose/day x 3days ISONIAZID 200mg/5ml 10-15 mkdose PO OD
Quantrel 100mg/5ml RIFAMPICIN 200mg/5ml 10-20 mkdose PO OD <6 mo: 0.5 mL BID
(Pyrantel Embonate) PYRAZINAMIDE 500mg/5ml 30-40 mkdose PO OD Mucosolvan Ped syr 15 mg/5 mL 5-10 yr: 5 mL BID-TID
(ambroxol) 2-5 yr: 2.5 mL TID
ETHAMBUTOL 20-25 mkdose PO OD
RACECADOTRIL <2 yr: 2.5mL BID
TD: 1.5 mkd TID STREPTOMYCIN 20-40 mkdose IM OD
Robikids 250 mg/5 mL susp 6-12 yr: 5 mL Q8
<9kg: 10mg TID (10mg/sachet)
Hidrasec (carbocisteine)
2-5 yr: 2.5 mL Q8
9-12kg: 20mg TID (2 sachet)
12-27kg: 30 mg TID (30mg/sachet) Solmux Broncho
>27: 60mg TID (2 sachet) Appebon kid syrup 2-12 yr: 5 mL OD (Salbutamol 2 mg, carbocisteine 500 mg) 7-12 yr: 2.5-5mL TID-QID
Nutrilin drops 7 mo-2 yr: 1 mL OD
RANITIDINE 0-6 mo: 0.5 mL OD Ventolin Expectorant syr >12 yr: 10-20 mL BID-TID
GERD/erosive esophagitis: (Per 5 mL syr Guaifenesin 50 mg, salbutamol
Nutrilin syr 7-12 yr: 5-10 mL OD 7-12 yr: 10 mL BID-TID
IV/IM: 2–4 mkday ÷ Q6–8; max. sulfate 1 mg)
Zantac 75,150,&300mg tab 2-6 yr: 5 mL. OD 2-6 yr: 5-10 mL BID-TID
dose: 200 mg/24 hr
25mg/ml amp Tiki Tiki Star syr 4-12 yr: 5 mL OD Combivent / Duavent >12 yr: 1-2 neb Q6-8
PO: 5–10 mkday ÷ Q8–12 hr. max
1-3 yr: 2.5-5 mL OD (Ipratropium Br 500 mcg, salbutamol 2.5 mg)
dose: 600mg/day 2-12 yr: 3 drops/kg/dose Q6-8
Immunosin syr 250 mg/5 mL TD: 500-100 mkday ÷ Q4-6 Seretide
Duodenal/gastric ulcer Immunosin tab 500 mg 7-12 yr: 5 mL (100 Diskus Salmeterol xinafoate 50 mcg,
Diskus ≥12 yr :1 inhalation of
IV/IM: 2–4 mkday ÷ Q6–8; max.
(Immunoplex) 3-6 yr: 3 mL fluticasone propionate 100 mcg. 250 Diskus Seretide 100 or 250 or 500 BID
Salmeterol xinafoate 50 mcg, fluticasone Diskus ≥4 yr: 1 inhalation of
dose: 200 mg/24 hr 1-2 yr: 2 mL propionate 250 mcg. 500 Diskus Salmeterol
7-12 mo: 1.5 mL xinafoate 50 mcg, fluticasone propionate 500 Seretide 100 BID
Tx: 4–8 mkday ÷ Q12 PO; max.
birth -6 mo: 1 mL mcg. 25/50 MDI Salmeterol xinafoate 25 mcg,
dose: 300 mg/day fluticasone propionate 50 mcg. 25/125 MDI
MD: 2–4 mkday ÷ Q12 PO; max. Salmeterol xinafoate 25 mcg, fluticasone
MDI ≥12 yr: 2 inhalations of
dose: 150 mg/day propionate 125 mcg. 25/250 MDI Salmeterol Seretide 25/50 or 25/125 or
xinafoate 25 mcg, fluticasone propionate 250 MDI ≥4 yr: 2 inhalations of
mcg)
SALMETEROL Persistent asthma: Alnix Plus Syr Seretide 25/50 BID
(Per 5 mL syr Cetirizine diHCl 5 mg, 6-12 yr: 5 mL BID
≥4 yr: 1 inhalation (50 mcg) Q12
phenylephrine HCl 5 mg) 2-5 yr: 2.5 m BID
SIMETHICONE
<2 yr: 20 mg PO QID PRN; max. Colvan drops & syrup
Restime 40mg/ml drops dose: 240 mg/24 hr (Per mL Colvan drops Phenylpropanolamine
HCl 6.25 mg, chlorphenamine maleate 0.25 mg
40mg chew tab 2–12 yr: 40 mg PO QID PRN Per 5 mL Colvan syr Phenylpropanolamine HCl
Disflatyl 40mg chew tab >12 yr: 40–250 mg PO QPC & QHS 12.5 mg, chlorphenamine maleate 0.5 mg) Drops 1-2 yr: 1 mL Q6
7-12 mo: 0.75 mL Q6
TERBUTALINE Oral: Disudrin drops & syrup 4-6 mo: 0.5 mL Q6
(Per mL drops Phenylephrine HCl 2.5 mg,
≤12 yr: 0.05 mkdose Q8 hr; max. chlorphenamine maleate 0.5 mg 1-3 mo: 0.25 mL Q6
Bricanyl 1.5mg/5ml syr dose: 0.15 mkdose or 5mg/day Per 5 mL syr Phenylephrine HCl 5 mg,
chlorphenamine maleate 1 mg)
2.5mg tab >12 yr: 2.5–5 mg/dose PO Q6–8 syr >12 yr: 10 mL Q6
5mg/2ml neb Nasatapp drops & syrup 7-12 yr: 5mL Q6
500mcg/ml amp Nebulization: (Per mL drops Phenylpropanolamine HCl 6.25 2-6 yr: 2.5 mL Q6
<2 yr: 0.5 mg in 2.5 mL NS Q4–6 mg, brompheniramine maleate 2 mg
Per 5 mL syr Phenylpropanolamine HCl 12.5
2–9 yr: 1 mg in 2.5 mL NS Q4–6 mg, brompheniramine maleate 4 mg)
>9 yr: 1.5–2.5mg in 2.5mL NS Q4–6
 HIDRASEC PEDIALYTE MILD 30
(Racecadotril) (Na 30 meq, K 20 meq, Mg 4 meq, Ca 4 meq, Cl 30 meq, lactate 28 meq. Energy: 20 kCal/100 mL)

Recommended Dose: 1.5 mg/kg per dose, with Dose: Total daily intake should be adjusted based on
an initial dose followed by 3 doses over the individual needs. Administration: May be taken with or
day. Administration: The powder should be without food.
In Practice swallowed as it is. It can also be added to food Prep: 500 mL oral sol’n (apple/grapes/strawberry)
>9 yr: 2 sachets (30 mg)/dose, or poured into a glass of water or a feeding
30 mo to 9 yr: 1 sachet (30 mg)/dose bottle, stirring well and ensuring that all the Pedialyte-45/Pedialyte-75/Pedialyte-90
9 mo to 30 mo: 2 sachets (10 mg)/dose, mixture is swallowed immediately.
(Per L Pedialyte-45 Cl 35 mEq, citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 45 mEq. Per L Pedialyte-
1 mo to 9 mo (<9 kg): 1 sachet (10 mg)/dose.
75 Cl 65 mEq, citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 75 mEq. Per L Pedialyte-90 Cl 80 mEq,
citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 90 mEq)
Prep: 10 & 30 mg sachet & 100 mg cap
Dose: Total daily intake should be adjusted based on
ERCEFLORA individual needs. Administration: May be taken with or
(Bacillus clausii) without food.
Prep: 500 mL oral sol’n
2-11 years: 1-2 vials of 2 billion/5 mL susp.
Administration at regular intervals (3-4 hrs),
>1 month: 1-2 vials of 2 billion/5 mL susp Glucost R
diluting the content of the vial in sweetened
water, milk, tea or orange juice. (Per L Pedialyte-45 Cl 35 mEq, citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 45 mEq. Per L Pedialyte-
Prep: 2 billion/5 mL vials
75 Cl 65 mEq, citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 75 mEq. Per L Pedialyte-90 Cl 80 mEq,
citrate 30 mEq, dextrose 25 g, K 20 mEq, Na 90 mEq)
PROTEXIN RESTORE
(Lactobacillus casei, Lactobacillus rhamnosus, Streptococcus thermophilus, Bifidobacterium breve, Mild dehydration
Lactobacillus acidophilus, Bifidobacterium infantis, Lactobacillus bulgaricus, fructooligosaccharide Deficit Therapy (to be given within 4-6
Childn 30 mL/kg
hrs): Dissolve 2 sachets in 200 mL of
(FOS)) Infant ≤2 yr 50 mL/kg
water. Can increased according to needs
Moderate dehydration
eg, 10 sachets in 1 L of water.
Recommended Dose: 1 sachet daily for 5-7 days Administration: Should be taken with food: Childn 60 mL/kg
or as needed. Take after meals. Contents of sachet may be Infant 100 mL/kg
Maintenance Therapy (to be given
Prep: sachet added to food/water/milk/juice. Maintenance therapy
within the next 24 hrs): Dissolve 1
Childn 60 mL/kg/day
sachet in 100 mL of water. Can increased
PROTEXIN VITALITY Infant 100 mL/kg/day
according to needs eg, 10 sachets in 1 L
(Lactobacillus casei, Lactobacillus rhamnosus, Streptococcus thermophilus, Lactobacillus acidophilus, of water
Prep: sachet
Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus bulgaricus, vit C, fructooligosaccharide
(FOS))
Hydrite
Recommended Dose: 1-2 tab daily for ≥4 yr Administration: May be taken with or (Per tab NaCl 350 mg, Na bicarbonate 250 mg, KCl 150 mg, anhydrous glucose 2 mg. Per sachet NaCl
Prep: chewable tab without food. 520 mg, trisodium citrate dihydrate 580 mg, KCl 300 mg, anhydrous glucose 2.7 g)

Administration: Direction: Dissolve 2 tabs or 1 sachet in every glass (200 mL) of drinking water. Give
as much fluid as the child wants until diarrhea or vomiting stops

Prevention of Dehydration

Treatment of Dehydration
 LUDAN’S METHOD Philippine EPI 2014 (Primary Doses) IVF glu Na Cl K C HCO Mg HPO
Hydration Phase Vaccine Sched Dose/Route/SIte a 3 4
Weight Mild Mod Sev D5W 50
P: Birth
< 10 kg 50cc/kg 100cc/kg 150cc/kg BCG .05ml ID R.deltoid D10W 100
B: School entry
>10 kg 30cc/kg 60cc/kg 90cc/kg D20W 200
D5 0.3% in 6-8 1st hr: 1/3 P: 6, 10, 14 wks
1st hr: ¼ PLRS D50-50 500
hrs PLRS OPV B1: 1 yr after P 0.5ml PO Mouth
0.45 77 77
5-7 hr: ¾ 5-7 hr: 2/3 B2: 4-6 yrs after B1 NaCl
D5LRS D50.3% P: 6, 10, 14 wks 3% 51 51
Maintenance Phase DTwP B1: 1 yr after P 0.5ml IM UOthigh NaCl 3 3
Weight FR if px has Respiratory Problem: use B2: 4-6 yrs after B1 PNSS 15 15
0-10 kg 100cckd lower TFR Hep B P: Birth, 6, 14 wks 4 4
11-20 kg 75cckd 0.5ml IM ALthigh D50.3 50 51 51
(monovalent) B: 5 years after
21-30 kg 60cckd NaCl
DTwP-Hib-Hep
>30 kg 50cckd P: 6, 10, 14 wks IM UOthigh D50.45 50 77 77
B (pentavalent) D50.9 50 15 15
P: 9 mos 4 4
HOLLIDAY-SEGAR METHOD Measles B1: 15 mos 0.5ml SC UOarm D5LRS 50 13 10 4 3 28
(Maintenance based on caloric expenditure) B2: 5-12 yrs 0 9
P: 12 mos PLRS 13 10 4 3 28
WATER MMR 0.5ml SC UOarm 0 9
Body Weight mL/kg/day mL/kg/hr B: 5-12 yrs after
Rotavirus P: 6, 10 wks PO mouth D5IMB 50 25 22 2 23 3 3
1st 10 kg 100 ≈4 0
2nd 10 kg 50 ≈2 Pneumococcal P: 6, 10, 14 wks 0.5ml IM/SC deltoid D5NM 50 40 40 1 3
Each additional kg 20 ≈1 3
D5NR 50 14 98 5 3
divide in 24hrs= ugtts/min 0
To calculate needed electrolytes: D5NM 50 40 57 3 3
Na+ 3 mEq/100 mL H20 K 0
K+ 2 mEq/100 mL H20
Cl2- mEq/100 mL H20

BODY SURFACE AREA

Hydration Phase for 6-8 hrs
SA 5%- usually used, SA 10% SA 15%

ugtts/min= [(wt in kgs/ 0.95)-wt in kgs] x 2000 / 6-8 hrs

3
Maintenance based on BSA

wt in kgs x 4 + 9 Ht (cm) x Wt (kg)

√
100 3600

TFR = BSA x 1500 mL/m2/24 hr

ugtts/min= (wt in kgs x 4 + 9) x 15
24
Surface Are Maintenance if with Fever
1. SA x 1500= A
2. x 10cc/kg/1°C rise in temp [Febrile T – Normal T
(37.5°C)] = B
3. (A+B) / 24 hrs= ugtts/min
 MILK FEEDING → Place in a bassinet & keep thermo -regulated bet 37.4-
36.6⁰C
3-5kgs 2oz 9xa day 0-2wks → NPO X 2H then may breastfeed
4.5-5.5 4oz 6xa day 2wks-3mo → VS Q15 until stable then Q2
→ I & O Q shift
6.5kgs 6oz 5xa day 3-6mo → For gastric lavage (for CS & mec stained)
→ AP informed of this admission
7.5kgs 6oz 4-5xa day 6mo&over
→ Refer accordingly

DISCHARGE CRITERIA FOR NEWBORN

NESTLE (1:1) MEAD JOHNSON (1:1) → (N) VS & PE
AL 110 Lactose Free Alacta 0-6mos → ability to suckle on breast effectively or by other methods
Alfare Alactamil 6mo-1y/o → doc adequacy in UO & SE
NAN H.W. 1,2 Enfalac A+ 0->1yr → completion of neonatal screening tests
NAN 1,2,3 Enfalac iron fortified 0->1y/o
NESTOGEN 1,2,3 Enfalac LF 0- >1y/o → complete anthropometrics measurements
NAN/NESTOGEN 3-10- Enfalac Premature → demonstration of maternal ability to care for her own
24mos Enfapro A+ infants baby
PRENAN Enfapro LF
Enfapro with DHA
BEAR BRAND 1+ Enfagrow AT >1y/o
NIDO Jr 1-3y/o Enfagrow LF WARD ADMITTING ORDERS
NIDO 3+ 3-5y/o Enfakid AT 3y/o & above (ADC VAN DISEL)
NIDO 5+ >5y/o
→ Admit to room of choice under the service of ______
PACIFIC HEALTHCARE (1:1) ABBOTT (1:2) → Diagnosis
Frisolac 0-6mos Isomil B-6mos → Condition (Stable or critical)
Frisomel 6mos-1yr Isomil 2 6mos onward → VS (frequency, usu. Q4 if stable
Frisogrow 1-3yr Similac advance 0-6mos → Activity (CBR, No bathroom prev, no limitations)
Frisokid 4-7yr Similac neosure 0-12mos (wt → Nursing Proc (Bedside proc including suctioning, draining,
gain) and HGT)
Grow >1y/o → Diet (NPO, soft diet, gen/clear liquids)
Gain + Advance >1y/o → I & O (usu Qshift)
Gain school Adv>3y/o
→ Specific fluids and drugs
UNILAB NUTRITIONALS (1:2) WYETH (1:2) → Extras
Hinulac >6mos Bonna: 0-6mos → Laboratory
Hinulac Excel 6-12 mos Bonnamil .6mos → AP informed of this admission
Mylac Promil >6mos → Refer accordingly
Mylac excel 0-12 mos Promil Gold>6mos
S26-B-6mos
S26 Gold B-6mos
S26 LF B-6mos
Progress Gold>1y/o
Promil Kid 1-3y/o
Promil preschool>3y
FONTERRA
Anchor 1-3y/o
Anchor 3+: 3-7yrs

NURSERY ADMITTING ORDERS

→ Pls admit to NSY under the service of ____
→ Secure consent for admission & mgmt
→ Routine newborn care:
- Terramycin Ophtalmic Eye ointment OU
- Vit K 1mg (IM) now
- Cord care with 70% Isopropyl alcohol TID